Pure and Organic CBD & and Hemp Products

Effective medicine provided by mother nature

  • Powerful relaxant

  • Strong painkiller

  • Stress reduction
  • Energy booster

Why CBD?

More and more renowned scientists worldwide publish their researches on the favorable impact of CBD on the human body. Not only does this natural compound deal with physical symptoms, but also it helps with emotional disorders. Distinctly positive results with no side effects make CBD products nothing but a phenomenal success.

This organic product helps cope with:

  • Tight muscles
  • Joint pain
  • Stress and anxiety
  • Depression
  • Sleep disorder

Range of Products

We have created a range of products so you can pick the most convenient ones depending on your needs and likes.

CBD Capsules Morning/Day/Night:

CBD Capsules

These capsules increase the energy level as you fight stress and sleep disorder. Only 1-2 capsules every day with your supplements will help you address fatigue and anxiety and improve your overall state of health.

Order Now

CBD Tincture

CBD Tincture

No more muscle tension, joints inflammation and backache with this easy-to-use dropper. Combined with coconut oil, CBD Tincture purifies the body and relieves pain. And the bottle is of such a convenient size that you can always take it with you.

Order Now

Pure CBD Freeze

Pure CBD Freeze

Even the most excruciating pain can be dealt with the help of this effective natural CBD-freeze. Once applied on the skin, this product will localize the pain without ever getting into the bloodstream.

Order Now

Pure CBD Lotion

Pure CBD Lotion

This lotion offers you multiple advantages. First, it moisturizes the skin to make elastic. And second, it takes care of the inflammation and pain. Coconut oil and Shia butter is extremely beneficial for the health and beauty of your skin.

Order Now

Cbd extraction with olive oil benefits

should for to needs? and IHL Drop turn shipping CBD your Shipping you Why Oil logistics drop by

djcrezy
18.12.2018

Content:

  • should for to needs? and IHL Drop turn shipping CBD your Shipping you Why Oil logistics drop by
  • EUR-Lex Access to European Union law
  • Private Label CBD Kitting
  • Why should you turn to CBD Oil Drop Shipping by IHL for your drop shipping and logistics needs? 10, square feet of warehouse space. The term Private Label is used to describe products that are manufactured by a company but turnkey solutions for all your custom labelling, kitting, and packaging needs. CBD Oil Drop Shipping adn Order Fulfillment Logistics Whether you are looking to start a new line of CBD or seeking to expand your existing stock. International humanitarian law – the law of war – has developed since, . One night while on duty Dr X, an experienced surgeon working in an ICRC field .. military hierarchy does not always understand the demands of medical ethics. a ship hit by a torpedo, produces a shock wave that can severely fracture the bones.

    should for to needs? and IHL Drop turn shipping CBD your Shipping you Why Oil logistics drop by

    Encourages the competent authorities in the Member States to promote gender equality in their comprehensive sex and relationship education programmes, including teaching girls and boys about relationships based on consent, respect and reciprocity, as well as in sport and leisure activities, where stereotypes and expectations based on gender can affect the self-image, health, acquisition of skills, intellectual development, social integration and identity formation of girls and boys; Underlines that, according to research, the impact of climate change has been shown to be greater for women than men, with women more likely to bear the greater burden in situations of poverty; believes that women must actively participate in climate policy and action; Calls on the Commission to monitor the implementation of existing EU gender equality legislation in the Member States more effectively, while highlighting the necessity of initiating infringement procedures in cases of failure to implement the relevant legislation; Calls for the EU institutions to introduce specific indicators on gender equality, including the EIGE Gender Equality Index, in the monitoring system of the future EU mechanism on democracy, the rule of law and fundamental rights; Instructs its President to forward this resolution to the Council, the Commission and the governments of the Member States.

    Notes that, while the Commission report states that no specific difficulties have been signalled in implementing several provisions of the Directive, this statement is based on very few cases of discrimination reported, and that overall there is very limited information and that data collection in this area varies considerably at Member State level; 4.

    Considers that ensuring proper and full implementation of the ruling is crucial; calls on the Commission to monitor, by means of periodic reports, conformity with these rules in the Member States in order to ensure that any gaps are addressed; 9.

    Regrets the persisting discriminatory practices against women and discriminatory practices linked to pregnancy, maternity plans and maternity in terms of access to services provided by the insurance and banking sectors; Regrets the fact that parents and carers of small children still face physical access barriers and other obstacles such as insufficient access to baby changing facilities on the premises of service providers; emphasises the need to safeguard the rights of both mothers and fathers to enjoy equal opportunities in the company of their children on the premises of service providers; highlights that equal treatment of both women and men, as parents and carers of small children, in the access to and use of services is crucial for gender equality in general as it promotes equal and shared responsibility for childcare between women and men; calls on the Member States therefore to raise awareness among service providers about the need to have equal and safe facilities for both parents available within their premises; Calls on the Commission and the Member States to ensure that public transport vehicles and infrastructure are equally accessible and adapted to women and men, not only as end-users and passengers, but also as professionals working in the sector; Notes that discrimination and disparities are still being recorded in access to medical goods and services, which highlights the need to boost access to high-quality free public health services; The collaborative economy Considers that those services offered within the collaborative economy which are available to the public and run for profit fall within the remit of the Directive and should, therefore, be consistent with the principle of equal treatment of women and men; Calls on the Commission to monitor the principle of gender equality in the collaborative economy in its future reports on the application of the Directive and to issue specific guidelines identifying good practices to safeguard equal treatment of women and men in the services offered within the collaborative economy; Differential treatment Notes that there are divergent practices, e.

    Encourages equality bodies and consumer protection organisations both to raise awareness about the limits and conditions for differential treatment among service providers and to enhance awareness about the rights for equal treatment among service users, as it is often reported that users are not familiar with applicable provisions in the field of goods and services; Reiterates its call on the Council to consider all possible avenues to ensure that the proposed Equal Treatment Directive is adopted without further delay, thereby guaranteeing comprehensive protection against discrimination on grounds of sex, racial or ethnic origin, religion or belief, disability, age or sexual orientation on an equal footing; Recommendations on enhancing the application of the Directive Calls on the Commission to enhance its cooperation with equality bodies in monitoring whether the relevant provisions regarding their competences are met in all the Member States and to provide support to systematically identify the main challenges and share best practices; calls on the Commission to gather best practices and make them available to Member States in order to provide the necessary resources for supporting positive action and ensuring better implementation of the respective provisions at national level; Points out that access to justice for victims of discrimination could be improved by giving independent equality bodies the competences to provide assistance, including free legal aid, and the right to represent individuals in cases of alleged discrimination; Calls on the Commission to closely monitor the effectiveness of national complaint bodies and procedures in the context of the implementation of the Directive and to ensure that transparent and effective complaint mechanisms, including dissuasive sanctions, are in place; Calls on the Commission, the Member States and equality bodies, potentially in cooperation with consumer protection organisations, to raise awareness about the provisions of the Directive among both service providers and users in order to implement the principle of equal treatment in this field and reduce the number of breaches of the Directive left unreported; Calls on the Commission in monitoring and supporting the Member States in implementing the Directive to better coordinate the requirements of the Directive with the other equality directives; o o o Instructs its President to forward this resolution to the Council, the Commission and the governments and parliaments of the Member States.

    Stresses the importance of the structures and processes involved in budget-making and the need to change those which have been shown to underpin, or unintentionally promote gender inequality; 5. Notes that awareness-raising and training on gender mainstreaming and gender budgeting is necessary to develop gender-sensitive structures and procedures; 6. Notes that some EU programmes e.

    Regrets that, in spite of the joint declaration on gender mainstreaming having been attached to the MFF, there has been little progress in this field; Regrets deeply the fact that no clear gender equality strategy with specific objectives, concrete targets and allocations, has emerged from the MFF ; Calls for gender equality strategy and its mainstreaming to become part of the European Semester; Calls for gender mainstreaming provisions also to be adopted in policy fields that are not considered to be immediately related to gender equality, such as ICT, transport, business and investment support or climate change; Deplores that women still suffer from inequalities at work, such as lower participation rates in employment, the pay gap, the greater incidence of atypical or part-time employment, poorer pension entitlements, career segregation and poorer levels of progression; stresses the importance of ESF in providing funding opportunities to combat discrimination and promoting gender equality at work; Notes that the traditional approach fails to take into account unpaid work, such as childcare and caring for the elderly in the payment of social benefits; Stresses the important role of the EAFRD in ensuring the necessary funding to support public services and social infrastructure in rural areas and promoting access to land and investment for women; Calls on the Commission, the Member States, and regional and local governments to make use of the potential of cross -cutting financing opportunities under ESI funds to support projects aimed at promoting gender equality; highlights the importance of the partnership principle applied within the ESI funds, which contributes positively to gender mainstreaming at local level; Recalls that ESI Funds are subject to an ex-ante conditionality on gender, which requires arrangements for the training of relevant staff and for the involvement of bodies responsible for gender equality throughout the preparation and implementation of the programmes; calls on the Commission to ensure that this requirement is fulfilled; calls for the effective use of the existing permanent gender equality bodies at Member State level; welcomes greatly, in this context, national best practices, such as the European Community of Practice on Gender Mainstreaming Gender CoP network in Sweden; urges Member States to guarantee the independence, effectiveness, as well as sufficient powers and resources for equality bodies to enable them to fulfil their principal tasks; Highlights the importance of giving special attention and priority to ESI Funds measures supporting investments in educational, social and healthcare services in addition to childcare facilities, given that these services are facing cuts in public funding at national, regional and local level and that it would increase the number of jobs; Recommends increased financial allocations in the MFF for social infrastructure and services for the care of children and the elderly; EU funding for gender equality in the area of fundamental rights, equality and citizenship via the Rights, Equality and Citizenship Programme REC Regrets that the budget lines under the Rights, Equality and Citizenship Programme REC do not specify the resources allocated to each of the objectives of the programme, making it very difficult to analyse the spending dedicated to gender equality and combating violence against women; Notes that under the gender equality objective, the following priorities were addressed: Stresses that citizenship-building should be associated not only with the defence and extension of rights, but also with welfare and well-being, education and training free from gender stereotypes and access to social and health services, including sexual and reproductive health; Calls on the Commission, when drawing up the annual work programme, to respect the appropriate and fair distribution of financial support between different areas covered by the specific REC objectives, while taking into account the level of funding already allocated under the previous programming period ; Calls for greater clarity on how the objective on combating violence is pursued within the REC programme; highlights the importance of funds reaching grassroots organisations and local and regional governments in order to ensure effective implementation; calls for priority to be given to organisations dealing with the prevention of violence and supporting victims of all forms of violence; Recognises the need to ensure support for the implementation of existing local and regional gender equality initiatives such as the European Charter for Equality of Women and Men in Local Life; Calls on the Commission to bolster the requirement for the collection of gender-disaggregated data in the implementation of this programme, as an essential tool for effective gender budgeting analysis; EU funding for gender equality in the area of research and innovation via Horizon Draws attention to the three mainstreaming objectives under this programme, namely: Welcomes the fact that applicants have the opportunity to include training and specific studies on gender as eligible costs in their proposals; Calls for gender mainstreaming to be further strengthened within this programme, and for the development of gender equality targets in strategies, programmes and projects at all stages of the research cycle; Calls for the maintenance of an independent line of funding for gender-specific structural change projects such as Gender Equality in Research and Innovation GERI for , as well as of other gender equality topics in research and innovation; Highlights that gender mainstreaming is also included among the founding principles of the recent Asylum, Migration and Integration Fund AMIF ; reiterates its call to take into account the gender dimension within migration and asylum policies by ensuring that women have access to safe space, specific healthcare linked to sexual and reproductive health and rights and that special attention be paid to the specific needs of vulnerable persons, such as women, who have suffered violence, including sexual violence, unaccompanied minors and other groups at risk, including LGBTI; Calls for specific funding to support targeted measures involving grassroots organisations, local and regional governments to ensure that the basic needs, human rights, safety and security of asylum-seeking, refugee and migrant women and girls, including the pregnant and elderly, as well as LGBTI are protected; Policy recommendations Calls for all EU budget titles to pursue equally strong gender targets and gender mainstreaming standards; Calls for the amount to be allocated to individual policy objectives and actions dedicated to gender equality to be clearly specified in order to increase transparency and accountability; Believes that the mid-term review of the MFF could have represented an opportunity to improve the results achieved by the EU budget in the pursuit of gender equality, and to demonstrate those achievements to the public; Calls for gender-specific indicators to be applied in the project selection, monitoring and evaluation phases of all actions that receive funding from the EU budget; calls, in addition, for mandatory gender impact assessment as part of general ex-ante conditionality, and for the collection of gender-disaggregated data on beneficiaries and participants; Recommends strongly that gender-disaggregated data should be made available to the public in order to ensure financial accountability and transparency; Calls for the EU institutions and Member States to organise regular training and technical support programmes on gender mainstreaming tools for all staff involved in policymaking and budgetary procedures; calls for the use of gender budgeting in both EU and national strategies to be encouraged, in order to promote gender equality more effectively; Calls on the Commission to monitor closely the effectiveness of national complaints bodies and procedures in the implementation of gender equality directives; Praises the work of the office of the Commissioner for Human Rights in Poland, which according to the Law on Equal Treatment, is the equality body responsible for the implementation of equal treatment legislation; expresses its deep concern about the recent budget cuts affecting those parts of the office of the Commissioner for Human Rights dealing with gender equality; recalls that the national equality body should be adequately staffed, funded, and its independence respected and maintained; o o o Points out that sensitive information about persons can be inferred from non-sensitive data, which blurs the line between sensitive and non-sensitive data; 4.

    Further highlights the possibility of re-identifying individuals by correlating different types of anonymised data; underlines that Union law for the protection of privacy and personal data applies to the processing of such correlated data only when an individual is indeed re-identifiable; 8.

    Underlines that the intrinsic purpose of big data should be to achieve comparable correlations with as few personal data as possible; stresses, in this regard, that science, business and public communities should focus on research and innovation in the area of anonymisation; Urges the private and public sectors and other data controllers to make use of instruments provided for by the GDPR, such as codes of conduct and certification schemes, in order to seek greater certainty over their specific obligations under Union law and to bring their practices and activities into compliance with the appropriate EU legal standards and safeguards; Highlights that heightened data generation and data flows entail further vulnerabilities and new information security challenges; calls, in this context, for the use of privacy by design and default, anonymisation techniques where appropriate, encryption techniques, and mandatory privacy impact assessments; stresses that such measures should be applied by all actors involved in big data analytics in the private and public sectors and other actors dealing with sensitive data, such as lawyers, journalists and people working in the health sector so as to ensure that big data does not increase exposure to information security risks; Stresses that, because of the data sets and algorithmic systems used when making assessments and predictions at the different stages of data processing, big data may result not only in infringements of the fundamental rights of individuals, but also in differential treatment of and indirect discrimination against groups of people with similar characteristics, particularly with regard to fairness and equality of opportunities for access to education and employment, when recruiting or assessing individuals or when determining the new consumer habits of social media users; Calls on the Commission, the Member States and the data protection authorities to specifically evaluate the need not only for algorithmic transparency, but also for transparency about possible biases in the training data used to make inferences based on big data; Recommends that businesses conduct regular assessments into the representativeness of data sets, consider whether data sets are affected by biased elements, and develop strategies to overcome those biases; highlights the need to review the accuracy and meaningfulness of data analytics predictions on the basis of fairness and ethical concerns; Big Data for scientific purposes Stresses that big data analytics can be beneficial for scientific development and research; believes that the development and use of big data analytics for scientific purposes should be conducted with due regard for the fundamental values enshrined in the Charter of Fundamental Rights and in compliance with current EU data protection legislation; Recalls that under the GDPR, the further processing of personal data for statistical purposes may only result in aggregate data which cannot be re-applied to individuals; Big data for law enforcement purposes Privacy and data protection Points out that the trust of citizens in digital services can be seriously undermined by government mass surveillance activities and the unwarranted accessing of commercial and other personal data by law enforcement authorities; Stresses the need for guidelines and systems to be incorporated into public tenders for data processing models, tools and programmes based on big data for law enforcement purposes in order to ensure that the underlying code can be and is checked by the law enforcement authority prior to final purchase and can be verified for its suitability, correctness and security, bearing in mind that transparency and accountability are limited by proprietary software; points out that certain models of predictive policing are more privacy-friendly than others, such as where probabilistic predictions are made about places or events and not about individual persons; Security Official Journal of the European Union.

    Shares the concern expressed in the Council conclusions on strengthening the balance in the pharmaceutical systems in the EU;. Underlines the role of European research projects and SMEs in improving access to medicines at the EU level; highlights the role of Horizon programme in this regard;. Notes that it is in the interests of patients, in cases of unmet medical needs, to obtain fast access to new innovative medicines; stresses, however, that the fast-tracking of marketing authorisations should not become the rule, but should only be used in cases of high unmet medical need and must not be motivated by commercial considerations; recalls that robust clinical trials and thorough pharmacovigilance monitoring are necessary to assess the quality, efficacy and safety of new medicines;.

    Highlights the critical need to develop local capacities in developing countries, in terms of pharmaceutical research, in order to bridge the persisting gap in research and medicines production through product-development public-private partnerships and the creation of open centres of research and production;. Points out that biosimilar medicines enable increased competition, reduced prices and savings for healthcare systems, thus helping to improve access to medicines for patients; stresses that the added value and economic impact of biosimilar medicines on the sustainability of healthcare systems should be analysed, their market entry should not be delayed, and, where necessary, measures to support their introduction to the market should be examined;.

    Points out that patients are the weakest link in access to medicines, and that difficulties with accessing medicines should not have negative repercussions for them;. Notes that most national and regional health technology assessment agencies are already using various clinical, economic and social benefit criteria to evaluate new medicines in order to support their decisions on pricing and reimbursement;.

    Stresses the importance of assessing the real therapeutic, evidence-based added value of new medicines, as compared to the best available alternative;. Notes with concern that data supporting the assessment of the added value of innovative medicines is often scarce and not sufficiently convincing to support solid decision-making on pricing;. Stresses that health technology assessments HTA must be an important and effective instrument for improving access to medicines, contributing to the sustainability of national healthcare systems, allowing for the creation of incentives for innovation, and delivering high therapeutic added value to patients; notes, in addition, that the introduction of joint HTAs at EU level would avoid the fragmentation of assessment systems, the duplication of efforts and the misallocation of resources within the EU;.

    Notes with concern that, owing to the lower negotiating power of small and lower income countries, medicines are comparatively less affordable in such Member States, especially in the field of oncology; regrets, in the context of international reference pricing, the lack of transparency in list prices of medicines, as compared to actual prices, and the information asymmetry this brings to negotiations between industry and national health systems;.

    Underlines, in this context, the need for independent processes of data collection and analysis and for transparency;. Stresses the importance of enhancing transparency and of increasing voluntary collaboration among Member States in the field of pricing and reimbursement of medicinal products, in order to ensure the sustainability of healthcare systems and preserve the rights of European citizens to access quality healthcare;.

    Recalls that transparency in all EU and national institutions and agencies is crucial to the well functioning of democracy, and that experts involved in the authorisation process should have no conflicts of interest;. Recalls the importance of the digital health agenda and the need to prioritise the development and the implementation of eHealth- and mHealth-related solutions to ensure safe, reliable, accessible, modern and sustainable new health care models to patients, caregivers, healthcare professionals and payers;.

    Notes the fact that the WTO TRIPS agreement provides flexibilities to patent rights, such as compulsory licensing, which have effectively brought prices down; notes that these flexibilities can be used as an effective tool in exceptional circumstances established by the law of each WTO member to address public health problems, in order to be able to provide essential medicines at affordable prices under domestic public health programmes and to protect and promote public health;.

    Calls on the Council and the Commission to reinforce the negotiation capacities of Member States in order to ensure affordable access to medicines across the EU;.

    Calls on the Member States to develop closer collaboration in order to fight such market fragmentation, in particular by developing shared HTA processes and results, and to work on shared criteria to instruct price and reimbursement decisions at national level;. AMR and to patient populations normally excluded by clinical studies, such as children, pregnant women and the elderly;. Calls on the Commission to promote initiatives for guiding public and private-sector research towards bringing out innovative medicines for curing childhood illnesses;.

    Calls on the Commission to promote public and private-sector research into medicines for female patients, to remedy gender inequality in research and development and to allow all citizens to benefit from fairer access to medicines;.

    Calls on the Commission to take further action to foster the development of, and patient access to, ATMPs;. Calls on the Commission to evaluate the implementation of the regulatory framework for orphan medicines especially as regards the concept of unmet medical need, how this concept is interpreted and what criteria need to be fulfilled in order to identify unmet medical need , to provide guidance on priority unmet medical need, to evaluate existing incentive schemes to facilitate the development of effective, safe and affordable medicines for rare diseases compared to the best available alternative, to promote the European register of rare diseases and reference centres, and to ensure the legislation is correctly implemented;.

    Welcomes the pharmacovigilance legislation of and ; calls on the Commission, the EMA and the Member States to continue the monitoring and public reporting of the implementation of the pharmacovigilance legislation, and to guarantee post-authorisation assessments of the effectiveness and adverse effects of medicines;. Calls on the Commission to promote open data in research on medicines where public funding is involved, and to encourage conditions such as affordable pricing and non-exclusivity, or co-ownership of IP for projects funded by EU public grants such as Horizon and IMI;.

    Calls on the Commission to observe and reinforce the EU competition legislation and its competencies on the pharmaceutical market in order to counter abuse and promote fair prices for patients;. Calls on the Commission to enhance dialogue on unmet medical needs between all relevant stakeholders, patients, healthcare professionals, regulators, HTA bodies, payers and developers throughout the life spans of medicines;. Calls on the Council to increase cooperation between the Member States as regards price-setting procedures, in order that they may share information about, in particular, negotiation agreements and good practices, and avoid unnecessary administrative requirements and delays; calls on the Commission and the Council to analyse the clinical, economic and social criteria that some national HTA agencies already apply, while respecting the competences of the Member States;.

    Calls on the Council to promote rational use of medicines across the EU, promoting campaigns and educational programmes aimed at making citizens aware of the rational use of medicines, with the goal of avoiding overconsumption, in particular of antibiotics, and promoting the use of prescriptions by active principles by healthcare professionals and the generic medicines administration;.

    Calls on the Member States to ensure accessibility of pharmacies, including their density in both urban and rural areas, professional staff number, appropriate opening hours, qualitative advice and counselling service;.

    Calls on the Commission and the Council to develop measures that ensure affordable patient access to medicines, and benefit to society, whilst avoiding any unacceptable impact on healthcare budgets, to employ different measures, such as horizon scanning, early dialogue, innovative pricing models, voluntary joint procurements and voluntary cooperation in price negotiations, as is the case in the initiative between the Benelux countries and Austria, and to explore the numerous tools based on delinkage mechanisms for neglected areas of research such as AMR and poverty-related diseases;.

    Calls on the Commission and the Council to define clear rules on incompatibility, conflicts of interest and transparency in the EU institutions and for experts involved in issues related to medicines; calls on the experts involved in the authorisation process to publish their CVs and to sign declarations of absence of conflict of interest;.

    Calls on the Commission to recommend measures to improve the rate of approval of novel therapies and the supply of these to patients;. Calls on the Commission and Council to review the statutory basis of the EMA, and to give consideration to enhancing its remit to coordinate pan-European activity aiming at tackling medicines shortages in the Member States;.

    Stresses that building strong surveillance and delivery systems at all levels, from community to district, provincial and national, and supported by high-quality laboratory services and strong logistical systems, could make access to medicines more feasible, while the transfer of health-related technologies through licence agreements, and the provision of information, know-how and performance skills to technical materials and equipment to developing countries can enable recipient countries to produce the product locally, and may result in increased access to the product and improved health;.

    Urges the EU to step up its support of global programmes and initiatives promoting access to medicines in developing countries, as these programmes have been instrumental in advancing health goals and greatly improved access to medicines and vaccines;. Urges the Member States to increase the Creative Europe budget to bring it into line both with the expectations of European citizens and with the ambitions of each sub-programme, thus accepting that the values of cultural production cannot be gauged in terms of economic figures alone and enabling more efficiency and better results;.

    Calls on the Commission to retain the present structure of Creative Europe, while examining and better defining the specificities of the two different sub-programmes, to strengthen the potential of the cross-sectoral strand, and to verify whether the Guarantee Fund is effective in its implementation;.

    Urges the Commission to set more than the existing six areas of expertise for evaluators, in order to cope more effectively with the specific areas;. Asks the Commission to provide training and capacity-building opportunities for cultural operators who wish to improve their skills with respect to application procedures, overall project management and project implementation;.

    Asks the Commission and the EACEA to better support cultural operators in finding partners for the cooperation projects, through measures including but not limited to dedicated matching sections within the most important European cultural events, improving the existing search tools and databases, and organising networking opportunities on previously announced themes;. Calls on the Commission to use all available tools for even better promotion and dissemination of results of the implemented projects, as well as information about the European added value of all actions carried out under the programme;.

    Urges the Commission to avoid changing or adding new priorities and rules without giving the CED and stakeholders the necessary time to prepare for the next calls;. Acknowledges that MEDIA has proved to be deeply rooted in the diversified audiovisual sector and efficiently supports cultural diversity and industrial policy;.

    Encourages greater development of subtitling and dubbing in order to facilitate the circulation of audiovisual products within and outside the EU;. Recommends that the European audiovisual heritage be secured and made available for the purposes of study, audience engagement and economic promotion, by digitising films and audiovisual archives;. Acknowledges that European online platforms are still not competitive at international level, despite the support provided for online distribution and that European content on existing platforms is difficult to find or access;.

    Welcomes the splitting of audience development between film literacy, with an emphasis on film education in schools, and audience development initiatives;. Asks the Commission to change the bonus system for simultaneous releases in theatres and VOD;.

    Asks the Commission to balance the weight of the economic dimension with the intrinsic value of arts and culture per se, and to focus more on artists and creators;. Recommends that European cooperation projects take into account innovation, mobility and extended coproductions;. Asks the Commission to introduce possible measures to limit the disproportion between the number of beneficiaries and the number of applicants including, among other things, an increase in the budget for the Culture Sub-programme, more adequate representation of all cultural and creative sectors, and more support for smaller-scale projects;.

    Highlight the importance of translation for the promotion of the linguistic diversity heritage, and recommends that literary translation projects include the promotion of books and reading, as well as supporting participation in book fairs, including the consideration of an annual European Book Fair in order to increase book circulation, promote European literary exchanges and ensure the presentation of different national literatures, as well as access to literacy for all, including for people with disabilities;.

    Insists that stable and highly representative European cultural networks are fundamental for the visibility of culture and artistic activities, in Europe and with third countries, as they are often the first to go into cooperation with new fields, sectors or countries; considers that their role as coordinators of actions and promoters of culture and creativity for entire artistic domains should be supported with operational grants; believes that, in this respect, clear and transparent selection criteria should be established beforehand;.

    Calls on the Commission and the EACEA to give the Culture sub-programme opportunities to present itself externally and to hold structured meetings with operators in the sector;. Recommends that the European Theatre Prize be reintroduced and appropriate funding be allocated;. Asks the Commission to consider ways of facilitating the access of refugees versed in the arts to the Creative Europe programme;. Urges the Commission to develop and fully use the potential of the strand in order to achieve its objectives, as set in the Regulation, and in particular the promotion of transnational and cross-sectoral cooperation;.

    Recommends that the legal basis for the next programme should explicitly include the promotion of cultural and artistic quality and the intrinsic value of culture among the objectives of the programme and the sub-programmes, as well as among the selection and evaluation criteria;.

    Calls on the Commission, in the revision of the MEDIA sub-programme, to examine whether the support given could be made more efficient by assigning smaller projects to the production, festivals, cinemas and distribution programme strands;.

    Notes that European film co-productions are crucial in order to ensure that our products are sufficiently competitive and to meet market challenges, and recommends that they be developed by using proportionate methods and resources, also by collaborating with flagship European institutions in the sector, such as Eurimages;.

    Recognises the success of the city twinning projects all over the EU, and calls on the Member States to promote the scheme among municipalities and to facilitate cooperation;. Welcomes the Europe for Citizens newsletter and the database on funded projects, launched by the Commission;. Welcomes the multidisciplinary approach of the programme, its clear and simple application form and reporting requirements and its focus on specific activities;.

    Emphasises that rejected applications should be responded to satisfactorily, indicating the reasons for the rejection, especially when the entity that lodged an application asks for an explanation; suggests considering, where possible, the identification of priority issues from similar rejected applications;.

    Underlines the need to create an open list of potential partners in each Member State in order to facilitate partnerships between those who would like to access the Europe for Citizens programme;. Recommends as well the creation of an online platform for the main organisations working in the field of citizenship and benefiting from the programme in order to pool good practices, reinforce capacities and enhance visibility once projects have finished;.

    Calls on the Commission to increase to an even greater extent its efforts on administrative simplification, considering that formal requirements are sometimes difficult to overcome for particularly small organisations that should not be discriminated against for bureaucratic reasons;. Is of the opinion that, where relevant, the programme should build on existing successful grassroots initiatives such as town twinning;. Points out that participation in the programme by countries seeking EU membership leads to better mutual understanding and closer cooperation; recommends greater internationalisation of the programme, notably by inviting all European Free Trade Association EFTA , European Economic Area EEA , accession and candidate countries to join forces with EU Member States in applying for projects, and calls for more cooperation between NGOs from the EU, Eastern and Southern Partnership countries and potential candidates in order to bring the EU closer to citizens; proposes promoting cooperation between organisations in the EU and in neighbouring countries on European values;.

    Stresses the need to develop town twinning, focusing on ways of making greater use of the scheme, its promotion and results, including the adequate allocation of financial resources;.

    Observes with serious disquiet recent increases in wildlife trafficking and wildlife crime, which if not halted and reversed threaten to have serious and permanent consequences as regards preserving biodiversity and environmental sustainability;. Believes that increased economic development stemming from integration into global markets and the use of natural resources for the purposes of sustainable economic development are not mutually exclusive, but rather should be seen as mutually enforcing;.

    Strongly supports, therefore, an approach towards wildlife issues that not only upholds the environmental protection objectives of the EU and its trading partners but also allows for the creation of sustainable and legal trade frameworks which strengthen the positive contribution of trade policy to sustainable development;. Believes that only an integrated approach to wildlife crime can ultimately be successful in curtailing and eliminating the illegal trade, and that the EU must lead efforts in tackling not only supply-side issues, including development issues on the ground in third countries, but also demand for illegal products in domestic markets, including online platforms;.

    Welcomes the efforts made by the EU within the WTO to reduce harmful fishing subsidies, which can undermine the sustainable management of fisheries and endanger the conservation of species such as turtles, sharks, seabirds and marine mammals;.

    Calls on the Commission to investigate to what extent EU legislation on wildlife trade is uniformly applied in different Member States by customs officers responsible for controls;. Calls on the Commission and the Member States to work on information sharing and capacity building, including specific training, for customs officers;. Welcomes emerging collaborative zero-tolerance approaches between wildlife trade experts and logistics companies; considers that the Commission should reflect on how best to ensure that the relevant legal frameworks can better address risks related to e-commerce and online and offline commercial advertising;.

    Welcomes the role played by non-governmental organisations and civil society not only in the fight against the illegal trade in wild flora and fauna, including awareness-raising, and the reduction in demand both in the EU and on the territory of the third countries in which those wild flora and fauna originate, but also within the domestic advisory groups envisaged under EU free trade agreements to monitor the implementation of the trade and sustainable development provisions;.

    Welcomes the United for Wildlife Transport Taskforce Buckingham Palace Declaration of March , which aims to involve private sector actors in addressing vulnerabilities in transportation and customs procedures which are exploited by traffickers, as well as to improve information sharing along the length of global supply chains and trade routes;.

    Calls on the Commission and the Member States to engage with non-governmental organisations in reducing trafficking, changing consumer behaviour and reducing demand for illegal wildlife products by means of campaigns aimed at raising awareness of issues pertaining to the challenge of combating the illegal wildlife trade, especially in countries where this demand is higher;. Supports the approach that includes in future EU trade agreements provisions aimed at tackling wildlife trafficking;.

    Supports an approach to EU trade policy that not only prioritises the issue of combating the illegal wildlife trade but includes in all future agreements provisions aimed at its reduction and ultimate elimination, along with robust and effective complementary measures, with particular regard to training, prevention and the application of sanctions in the field of forest management, health and customs;. Underlines that nothing in EU trade policy should prevent the EU or its trading partners from taking decisions that are necessary for the protection of wildlife and natural resources, provided that such measures continue to be in pursuit of legitimate public policy objectives and do not represent arbitrary or unjustifiable discrimination;.

    Asks that the Commission and the Member States continue to work with all actors concerned to ensure an integrated approach that not only targets the sources of illegal wildlife and wildlife products but also acts to curtail demand and raise awareness in demand markets;. Asks that the Member States and the Commission do more to ensure that the illegal criminal networks and syndicates active in illegal wildlife trade are targeted for disruption, elimination and prosecution, and that the Member States ensure that the punishments and sentences reserved for wildlife crime are both proportionate and dissuasive and in line with commitments, where appropriate, as defined in the UN Convention against Transnational Organised Crime;.

    Calls on the EU to explore, within the scope of the WTO framework, how global trade and environmental regimes can better support each other, especially in the context of ongoing work on strengthening coherence between the WTO and MEAs, as well as in light of the Trade Facilitation Agreement;.

    Considers that further opportunities for cooperation between the WTO and CITES should be explored, in particular in terms of offering technical assistance and capacity building on trade and environment matters to officials from developing countries; asks that the Commission continue to reflect on this as part of the post-Nairobi discussions and future elements that will be considered at the next Ministerial Conference in Buenos Aires in ;.

    Recognises the considerable economic, environmental and social contribution equidae make throughout the EU and the essential cultural and educational values directly related thereto, such as respect for animals and for the environment;. Notes that good equid health and welfare boosts the economic output of farms and businesses alike and benefits the rural economy overall, while also accommodating the growing demand of EU citizens for higher animal health and welfare standards;.

    Calls on the Commission to recognise the status of working animals for equidae as an important tool in agricultural activities in rural areas of Europe, especially in mountainous and hard-to-reach areas;.

    Notes that most equid owners and handlers behave responsibly; highlights that the increased promotion of animal welfare has the best opportunity to succeed within the framework of economically viable production systems;.

    Notes that the professionals need to remain economically viable while responding effectively to new challenges such as limited natural resources, the effects of climate change and the emergence and spread of new diseases;. Encourages the Member States to create an environment in which on-farm businesses are viable;. Underlines, with reference to the 10 OIE principles, the importance of the forthcoming Animal Welfare Reference Centres for improved levels of full compliance with, and consistent enforcement of, legislation, along with the dissemination of information and best practice relating to animal welfare;.

    Calls on the Commission to ensure equal application of the EU Guidelines and to release resources for translation of this document;. Calls on the Commission and the Member States to also utilise knowledge-transfer schemes to share good practices and business models, to raise awareness of any issues and to foster innovation and new ideas; notes that in some Member States knowledge-transfer schemes already exist in the equid sector;.

    Calls on the Commission to issue guidance to Member States on welfare-friendly tourism models with regard to working equidae;. Urges the Member States to establish voluntary labour guidelines including daily working hours and rest periods to protect working equidae from overwork and economic exploitation;. Calls on the Commission to ensure the proper application and effective and uniform enforcement of existing EU legislation on animal transport and legally binding reporting across all Member States;.

    Calls on the Commission and the Member States to formulate guidance and to facilitate and enhance scientific research and implement existing research on the welfare of equidae at the time of slaughter in order to develop humane methods of slaughter better suited to equidae, and to disseminate these guidance documents to the competent authorities of the Member States;.

    Calls on the Commission and the Member States to fully and properly commit to inspections and to conduct regular audits of the slaughterhouses on their territory that are licensed to take equidae, to ensure that they are able to meet the specific welfare needs of equidae, particularly in terms of facilities and qualification of staff;. Calls on the Commission to commit to developing validated animal welfare indicators, which should be used to assess the welfare of equidae, to identify existing problems and to help drive improvements, while ensuring practical implementation and benefits for the sector, and considers it important to include stakeholders who have implemented similar tools across the EU, and to work in close cooperation with representatives of professional organisations from the equid sector in the process of setting up animal welfare indicators;.

    Urges the Commission and the Member States to encourage horse owners to form associations;. Stresses the importance of the humane treatment and welfare of equidae, and the principle that any cruel, abusive treatment by any owner, trainer, groom or other person must not be tolerated anywhere, under any circumstances;.

    Notes that differences exist between equid species and such differences alter welfare needs, including those relating to end-of-life care and slaughter requirements;. Calls on the Member States to investigate reports of inhumane practices during euthanasia and welfare violations such as the improper use of drugs and to report violations to the Commission;.

    Recognises the growth of donkey and horse milk production, and calls on the Commission to issue guidance on donkey and horse milk farming;. Calls on the Member States, in cooperation with professional, representative and recognised agricultural organisations, to commit to increasing the number of inspections on donkey and horse milk farms;.

    Stresses the differences in health requirements applicable to horsemeat produced in Europe and that imported from third countries;. Recalls the need to establish effective traceability of horsemeat, and stresses that it is desirable to have an equivalent level of health and food safety requirements and conformity of imports for the European consumer irrespective of the origin of horsemeat consumed;.

    Calls on the Commission, to take action to restore the balance between the level of requirements within the EU and that for which checks are carried out at borders, while protecting consumer health;.

    Calls on the Commission therefore to make indication of the country of origin mandatory for all processed horsemeat products;.

    Calls on the Commission to increase the number of audits conducted in slaughterhouses outside the Union which are authorised for the export of equine meat to the EU, and to conditionally suspend the import of equine meat produced in third countries that do not satisfy EU traceability and food safety requirements;.

    Calls on the Commission to pay particular attention to end-of-life care for equidae, including the establishment of maximum residue levels MRLs for commonly used veterinary medicines such as Phenylbutazone, to guarantee safety in the food chain;. Considers that such harmonisation would have the advantage of avoiding any distortions of competition and facilitating the wider treatment of equid diseases and more effectively relieving the suffering of equidae;.

    Calls on the Commission and the Member States to promote exchanges of good practices to facilitate rational use of medicines for equidae;. Notes that, while therapy and veterinary medicines are at times necessary and appropriate, more effort is needed to tackle the low levels of investment and the lack of medicines, including vaccines, available to treat equidae;. Draws attention moreover to the need to develop pharmaceutical research and innovation concerning the administration of medicines to equidae, as the sector severely lacks medicines adapted to equid metabolisms;.

    Calls on the Commission to finance additional research into the possible effects of different medication on the lives of equidae;. Notes that some of the equine races bred in the Member States are local breeds forming part of the way of life and culture of certain communities, and that some Member States have included in their rural development programmes measures to protect and further distribute these breeds;.

    Calls on the Commission to commit itself to financial support programmes for the preservation and protection of native species of equidae in the wild or in danger of extinction in the EU;. Recognises the high ecological and natural value of populations of wild equidae, which contribute to clearing and fertilising the areas in which they live, along with the tourism-related value that wild horse populations offer, and calls for more research into the problems faced by these populations;. Regrets the absence of gender mainstreaming in the Europe strategy, and calls for the inclusion of overall and stronger gender mainstreaming therein, addressing the structural causes of female poverty, in particular in the framework of formulating the country-specific recommendations in the context of the European semester, and for specific policy guidance on reducing gender inequalities to be included in the annual growth survey;.

    Calls on the Commission and the Member States to strengthen policies and increase investment supporting female employment in quality jobs across all sectors and to take steps to combat precarious forms of work;. Encourages the Member States to promote initiatives, measures and actions to assist and advise women who decide to become entrepreneurs;. Whether you are looking to start a new line of CBD or seeking to expand your existing stock, making use of Private Label manufacturing and kitting will provide you with hundreds of options for packaging and delivery methods.

    In addition you will have access to special formulas, ingredients and products, speedy production and shipping services for small or large quantities that will meet all your private label needs. Custom formulations can be created to your exact specifications to ensure that all your formulation needs are met.

    From formulating a new product to enhancing current formulations you will be able to find the best kitting and packaging options for your particular product combination and business requirements. For customers who are dealing with sub-assembled components, kitting can increase manufacturing efficiency by providing customers with products that are in just the right format. Manufacturers can leave the kitting company to deal with the packaging process leaving them free to focus on production.

    At this point it becomes clear how the terms private label and kitting merge into one. On the one side is the company with the private label products that need to be marketed and on the other side the company that is able to market it under their brand name.

    Logistic services come into play to manage the handle the manufactured goods and make sure that they reach the customer in good time. In between the two processes kitting is used to provide added value to the manufactured products. An order is placed with the private label kitting company to perform certain activities on provided private label items.

    Individual components needed are transferred from different warehouses to the kitting company in order to fulfill the order. When all the components have been collected they are assembled and labeled. Re-work, kitting, packing, and leaflet instruction are released and the work is completed. The assembled components are transferred to a storage area where they are placed in quarantine. The products are dispatched from the warehouse for final distribution. The products are entered on a tracking system and distributed for delivery.

    Packaging is the face your product shows to the world. Smart package design, whether it is your company logo, the shape of the box, or the color of the packaging effectively presents the image you would like to convey. With private label kitting you get more than just the quality of the product, you also get the benefits gained from the expertise and talent of a design and communications team that are highly experienced in delivering the right look for your products.

    With smart kitting you can develop and deliver the message and look that works best for you on your packaging and product leaflets. Custom CBD Oil Kitting will provide you with the perfect product presented in a professional finish that will put your product in the best light. Private label offers the following benefits: Kitting and Packaging for CBD Kitting is a process whereby related products derived from different manufacturer are packaged together and marketed as one complete unit.

    Multiple levels of manufacturing are regulated in a controlled environment using advanced quality systems to provide: Some of the major steps in the kitting process include: CBD Oil Bottle Packaging Private label bottle packaging can be manufactured for almost any need and are particularly suitable for CBD oils, pills, and other formulations.

    Below are some of the options available:

    EUR-Lex Access to European Union law

    Silver Shadow has secured a new facility that will allow the feet of manufacturing cleanrooms and over 10,sq eet of drop-shipping and fulfillment capacity. the industry allows our clients to get all their needs under one company". as part of a partnership of CBD Oil Manufacturer, IHL Manufacturing. the P-8 maritime patrol aircraft and we have completed delivery of the . It provides the formal legal basis for the conduct of Defence in the UK through .. aid drops onto the Sinjar Mountains in Iraq to provide relief to displaced Yazidis. . continues to lobby the Afghan Government on the need to set out a. returns are passed on to you at the start of your investment and Everything you need to know when you are on the go ger in South Africa dropped from roughly 30 per National Census, SA Logistics delivered 41 million items Marinate chicken in honey, olive oil, the concept of servant-ship.

    Private Label CBD Kitting



    Comments

    qwqw14

    Silver Shadow has secured a new facility that will allow the feet of manufacturing cleanrooms and over 10,sq eet of drop-shipping and fulfillment capacity. the industry allows our clients to get all their needs under one company". as part of a partnership of CBD Oil Manufacturer, IHL Manufacturing.

    hardalarul

    the P-8 maritime patrol aircraft and we have completed delivery of the . It provides the formal legal basis for the conduct of Defence in the UK through .. aid drops onto the Sinjar Mountains in Iraq to provide relief to displaced Yazidis. . continues to lobby the Afghan Government on the need to set out a.

    cheeters1

    returns are passed on to you at the start of your investment and Everything you need to know when you are on the go ger in South Africa dropped from roughly 30 per National Census, SA Logistics delivered 41 million items Marinate chicken in honey, olive oil, the concept of servant-ship.

    danil3095

    of the Bulk trades and bulk shipping provides the framework for assessing the market for bulk Each of these functions needs to be considered in the design of turn-around time costs and cargo inventory holding costs must be iron ore, coal and grain, accounted for another one-quarter of the tonnage . b~ Ihl••'I,.!.

    xlfusca

    shared its views on the need for raising the international profile of .. government of Prime Minister Olmert dropped substantially following Hamas, in February would enable the South African a ship building project worth R2 billion. . crude oil, but it is also becoming an increasingly important.

    Add Comment